Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

Suntory Holdings Chairman Niinami resigns

TOKYO, Japan, Sept. 2 Kyodo - Suntory Holdings Ltd. President Nobuhiro Torii and Vice President Kenji Yamada bow in apology at a press conference in Tokyo on Sept. 2, 2025, after announcing the resignation of the company's Chairman Takeshi Niinami, also chairman of the Japan Association of Corporate Executives. The 66-year-old was under police investigation over dietary supplements he allegedly purchased, according to the major Japanese brewer. (Kyodo)

E

Suntory Holdings Chairman Niinami resigns

Suntory Holdings Ltd. President Nobuhiro Torii (L) and Vice President Kenji Yamada bow in apology at a press conference in Tokyo on Sept. 2, 2025, after announcing the resignation of the company's Chairman Takeshi Niinami, also chairman of the Japan Association of Corporate Executives. The 66-year-old was under police investigation over dietary supplements he allegedly purchased, according to the major Japanese brewer.

E

Japan health minister speaks over supplements scandal

Japanese health minister Keizo Takemi speaks to reporters at the ministry in Tokyo on July 23, 2024, over a health hazard scandal linked to Kobayashi Pharmaceutical Co.'s red yeast rice dietary supplements.

E

Japan health minister speaks over supplements scandal

Japanese health minister Keizo Takemi speaks to reporters at the ministry in Tokyo on July 23, 2024, over a health hazard scandal linked to Kobayashi Pharmaceutical Co.'s red yeast rice dietary supplements.

E

Japan health minister speaks over supplements scandal

Japanese health minister Keizo Takemi speaks to reporters at the ministry in Tokyo on July 23, 2024, over a health hazard scandal linked to Kobayashi Pharmaceutical Co.'s red yeast rice dietary supplements.

E

Kobayashi Pharmaceutical dietary supplements

File photo taken in Osaka on April 7, 2024, shows pills of "beni-koji" red yeast rice dietary supplements manufactured by Kobayashi Pharmaceutical Co. Five deaths and about 250 hospitalizations have been reported to be possibly linked to the consumption of the product.

E

Kobayashi Pharmaceutical factory in Osaka

Photo taken March 27, 2024, shows a factory belonging to Kobayashi Pharmaceutical Co. in the western Japan city of Osaka. Five deaths and about 250 hospitalizations have been reported to be possibly linked to the consumption of the company's "beni-koji" red yeast rice dietary supplements.

E

Kobayashi Pharmaceutical dietary supplements

File photo taken in Osaka on April 7, 2024, shows bags of "beni-koji" red yeast rice dietary supplements manufactured by Kobayashi Pharmaceutical Co. Five deaths and about 250 hospitalizations have been reported to be possibly linked to the consumption of the product.

E

Kobayashi Pharmaceutical dietary pills scandal

OSAKA, Japan, March 29 Kyodo -Kobayashi Pharmaceutical Co. President Akihiro Kobayashi (C) attends a press conference in the western Japan city of Osaka on March 29, 2024. The company said the same day it has confirmed a fifth death linked to the consumption of its red yeast rice dietary supplements and that it has yet to determine the substance that may be responsible for the deaths.(Kyodo)

E

Japan's Kobayashi Pharma factory inspected amid supplement health scare

STORY: Japan's Kobayashi Pharma factory inspected amid supplement health scare SHOOTING TIME: March 29, 2024 DATELINE: March 31, 2024 LENGTH: 00:01:28 LOCATION: Tokyo CATEGORY: HEALTH SHOTLIST: 1. various of Kobayashi Pharmaceutical's headquarters in the city of Osaka 2. various of the recalled three products containing Kobayashi Pharmaceutical's beni-koji 3. various of Kobayashi Pharmaceutical's products in Japan's drugstores STORYLINE: Japan's health ministry and local authorities on Saturday inspected the Osaka factory of Kobayashi Pharmaceutical following reports of deaths and hospitalizations possibly linked to its dietary supplements containing red yeast rice, known as "beni-koji." The factory in western Japan, which was making the ingredients of the product named Beni-koji Choleste Help, a type of granules advertised with the effect of lowering LDL cholesterol levels, shut down in December. However, the Ministry of Health, Labour and Welfare and the Osaka city government decided to carry out

E

Authorities search Kobayashi Pharmaceutical's Osaka factory

Japanese health ministry officials search a Kobayashi Pharmaceutical Co. factory in Osaka, western Japan, on March 30, 2024, following reports of deaths and hospitalizations possibly linked to its red yeast rice dietary supplements.

E

Authorities search Kobayashi Pharmaceutical's Osaka factory

Japanese health ministry officials search a Kobayashi Pharmaceutical Co. factory in Osaka, western Japan, on March 30, 2024, following reports of deaths and hospitalizations possibly linked to its red yeast rice dietary supplements.

E

Authorities search Kobayashi Pharmaceutical's Osaka factory

Japanese health ministry officials search a Kobayashi Pharmaceutical Co. factory in Osaka, western Japan, on March 30, 2024, following reports of deaths and hospitalizations possibly linked to its red yeast rice dietary supplements.

E

JAPAN-OSAKA-HEALTH-KOBAYASHI PHARMACEUTICAL-DIETARY SUPPLEMENTS-DEATH TOLL

(240329) -- OSAKA, March 29, 2024 (Xinhua) -- President of Kobayashi Pharmaceutical Akihiro Kobayashi (2nd L) speaks at a press conference in the city of Osaka, Japan, March 29, 2024. Japanese drugmaker Kobayashi Pharmaceutical on Friday confirmed a fifth death related to its dietary supplements with red yeast rice, or beni-koji, produced by the company. (Xinhua/Zhang Xiaoyu)

E

JAPAN-OSAKA-HEALTH-KOBAYASHI PHARMACEUTICAL-DIETARY SUPPLEMENTS-DEATH TOLL

(240329) -- OSAKA, March 29, 2024 (Xinhua) -- President of Kobayashi Pharmaceutical Akihiro Kobayashi speaks at a press conference in the city of Osaka, Japan, March 29, 2024. Japanese drugmaker Kobayashi Pharmaceutical on Friday confirmed a fifth death related to its dietary supplements with red yeast rice, or beni-koji, produced by the company. (Xinhua/Zhang Xiaoyu)

E

JAPAN-OSAKA-HEALTH-KOBAYASHI PHARMACEUTICAL-DIETARY SUPPLEMENTS-DEATH TOLL

(240329) -- OSAKA, March 29, 2024 (Xinhua) -- The headquarters of Kobayashi Pharmaceutical is seen in the city of Osaka, Japan, March 29, 2024. Japanese drugmaker Kobayashi Pharmaceutical on Friday confirmed a fifth death related to its dietary supplements with red yeast rice, or beni-koji, produced by the company. (Xinhua/Zhang Xiaoyu)

E

JAPAN-OSAKA-HEALTH-KOBAYASHI PHARMACEUTICAL-DIETARY SUPPLEMENTS-DEATH TOLL

(240329) -- OSAKA, March 29, 2024 (Xinhua) -- President of Kobayashi Pharmaceutical Akihiro Kobayashi attends a press conference in the city of Osaka, Japan, March 29, 2024. Japanese drugmaker Kobayashi Pharmaceutical on Friday confirmed a fifth death related to its dietary supplements with red yeast rice, or beni-koji, produced by the company. (Xinhua/Zhang Xiaoyu)

E

JAPAN-OSAKA-HEALTH-KOBAYASHI PHARMACEUTICAL-DIETARY SUPPLEMENTS-DEATH TOLL

(240329) -- OSAKA, March 29, 2024 (Xinhua) -- President of Kobayashi Pharmaceutical Akihiro Kobayashi (2nd L) and others bow at a press conference in the city of Osaka, Japan, March 29, 2024. Japanese drugmaker Kobayashi Pharmaceutical on Friday confirmed a fifth death related to its dietary supplements with red yeast rice, or beni-koji, produced by the company. (Xinhua/Zhang Xiaoyu)

E

Kobayashi Pharmaceutical dietary pills scandal

Kobayashi Pharmaceutical Co. President Akihiro Kobayashi (C) attends a press conference in the western Japan city of Osaka on March 29, 2024. The company said the same day it has confirmed a fifth death linked to the consumption of its red yeast rice dietary supplements and that it has yet to determine the substance that may be responsible for the deaths.

E

Kobayashi Pharmaceutical dietary pills scandal

Kobayashi Pharmaceutical Co. President Akihiro Kobayashi speaks at a press conference in the western Japan city of Osaka on March 29, 2024. The company said the same day it has confirmed a fifth death linked to the consumption of its red yeast rice dietary supplements and that it has yet to determine the substance that may be responsible for the deaths.

E

Kobayashi Pharmaceutical dietary pills scandal

Kobayashi Pharmaceutical Co. President Akihiro Kobayashi (R) apologizes at a press conference in the western Japan city of Osaka on March 29, 2024. The company said the same day it has confirmed a fifth death linked to the consumption of its red yeast rice dietary supplements and that it has yet to determine the substance that may be responsible for the deaths.

E

Kobayashi Pharmaceutical dietary pills scandal

Kobayashi Pharmaceutical Co. President Akihiro Kobayashi (2nd from L) attends a press conference in the western Japan city of Osaka on March 29, 2024. The company said the same day it has confirmed a fifth death linked to the consumption of its red yeast rice dietary supplements and that it has yet to determine the substance that may be responsible for the deaths.

E

Kobayashi Pharma shareholders' meeting in Osaka

A Kobayashi Pharmaceutical Co. shareholder (R) speaks to reporters ahead of the company's annual shareholders' meeting in the western Japan city of Osaka on March 28, 2024. The company said it has confirmed two more deaths linked to the consumption of its red yeast rice dietary supplements which had already been implicated in two other deaths from kidney-related conditions and over 100 hospitalizations.

E

Kobayashi Pharma shareholders' meeting in Osaka

A person heads to the venue of Kobayashi Pharmaceutical Co.'s annual shareholders' meeting in the western Japan city of Osaka on March 28, 2024. The company said it has confirmed two more deaths linked to the consumption of its red yeast rice dietary supplements which had already been implicated in two other deaths from kidney-related conditions and over 100 hospitalizations.

E

2 die, 100 hospitalized after consuming Japan drugmaker's supplements

OSAKA,Japan, March 27 Kyodo - Two people are believed to have died and over 100 hospitalized after consuming red yeast rice dietary supplements from Kobayashi Pharmaceutical Co., the Japanese drugmaker and the health ministry said Tuesday, amid swelling safety concerns over the products.(Kyodo)

E

China Brand Expo of Healthcare Ingredients concludes in U.S. Las Vegas

STORY: China Brand Expo of Healthcare Ingredients concludes in U.S. Las Vegas DATELINE: Oct. 29, 2023 LENGTH: 00:01:30 LOCATION: LAS VEGAS, U.S. CATEGORY: ECONOMY SHOTLIST: 1. various of the fourth China Brand Expo of Healthcare Ingredients STORYLINE: The fourth China Brand Expo of Healthcare Ingredients concluded Thursday in the U.S. city of Las Vegas amid applauds and hails from business insiders from all around the world. The two-day event organized by the China Chamber of Commerce for Import & Export of Medicines and Health Products (CCCMHPIE) was co-located with SupplySide West 2023, the annual flagship show in the nutraceutical manufacturing industry of North American market, which concluded Friday. China Brand selected nearly 100 elite enterprises from 22 provincial regions of China, which showcase various ingredients and solutions for dietary supplements, functional food & beverage, pharmaceuticals, and personal care, among others. The trade show, which had been suspended for three years due to

E

Fancl Health Science to sell genetic testing kit

TOKYO, Japan - A genetic testing kit is unveiled in Tokyo on Oct. 21, 2014, by Fancl Health Science, a subsidiary of cosmetics maker Fancl Corp., for sale from November at prices starting from 14,800 yen. Based on the user's genetic data, the company will predict likely lifestyle-related illnesses and recommend specific dietary supplements to prevent them.

E

Fancl Health Science to sell genetic testing kit

TOKYO, Japan - A genetic testing kit is unveiled in Tokyo on Oct. 21, 2014, by Fancl Health Science, a subsidiary of cosmetics maker Fancl Corp., for sale from November at prices starting from 14,800 yen. Based on the user's genetic data, the company will predict likely lifestyle-related illnesses and recommend specific dietary supplements to prevent them. (Kyodo)

E

mcePharma company

The producer of dietary supplements, animal food and healthy food mcePharma company in Bilovec, Czech republic, on May 20, 2020. (CTK Photo/Jaroslav Ozana)

E

Katerina Heczkova, mcePharma company

The specialist Katerina Heczkova of the producer of dietary supplements, animal food and healthy food mcePharma company in Bilovec, Czech republic, on May 20, 2020. (CTK Photo/Jaroslav Ozana)

E

Katerina Heczkova, mcePharma company

The specialist Katerina Heczkova of the producer of dietary supplements, animal food and healthy food mcePharma company in Bilovec, Czech republic, on May 20, 2020. (CTK Photo/Jaroslav Ozana)

E

mcePharma company

The producer of dietary supplements, animal food and healthy food mcePharma company in Bilovec, Czech republic, on May 20, 2020. (CTK Photo/Jaroslav Ozana)

E

mcePharma company

The producer of dietary supplements, animal food and healthy food mcePharma company in Bilovec, Czech republic, on May 20, 2020. (CTK Photo/Jaroslav Ozana)

E

Katerina Heczkova, mcePharma company

The specialist Katerina Heczkova of the producer of dietary supplements, animal food and healthy food mcePharma company in Bilovec, Czech republic, on May 20, 2020. (CTK Photo/Jaroslav Ozana)

E

mcePharma company

The producer of dietary supplements, animal food and healthy food mcePharma company in Bilovec, Czech republic, on May 20, 2020. (CTK Photo/Jaroslav Ozana)

E

mcePharma company

The producer of dietary supplements, animal food and healthy food mcePharma company in Bilovec, Czech republic, on May 20, 2020. (CTK Photo/Jaroslav Ozana)

E

Katerina Heczkova, mcePharma company

The specialist Katerina Heczkova of the producer of dietary supplements, animal food and healthy food mcePharma company in Bilovec, Czech republic, on May 20, 2020. (CTK Photo/Jaroslav Ozana)

E

Katerina Heczkova, mcePharma company

The specialist Katerina Heczkova of the producer of dietary supplements, animal food and healthy food mcePharma company in Bilovec, Czech republic, on May 20, 2020. (CTK Photo/Jaroslav Ozana)

E

Andrea Dolezalova, mcePharma company

Andrea Dolezalova, the managing director of the producer of dietary supplements, animal food and healthy food mcePharma company in Bilovec, Czech republic, on May 20, 2020. (CTK Photo/Jaroslav Ozana)

E

Katerina Heczkova, mcePharma company

The specialist Katerina Heczkova of the producer of dietary supplements, animal food and healthy food mcePharma company in Bilovec, Czech republic, on May 20, 2020. (CTK Photo/Jaroslav Ozana)